Opportunity
Alberta Purchasing #AB-2026-02304
Award of Off Patent Oncology Pharmaceutical Products to Multiple OEMs for Canadian Healthcare Institutions
Posted
March 18, 2026
Identifier
AB-2026-02304
NAICS
424210
This award notice details the results of HealthPRO Procurement Services Inc.'s RFP for off patent oncology pharmaceutical products: - Government Buyer: - HealthPRO Procurement Services Inc., a Canadian group purchasing organization for healthcare institutions - OEMs and Vendors: - Fresenius Kabi - Hikma Canada Limited - JAMP Pharma Corporation - Marcan Pharmaceuticals Inc. - Pharmascience Inc. - Products Requested: - Oncology pharmaceutical products, identified by part numbers: - PH100BL_A1 (Fresenius Kabi) - PH101NMa (Hikma Canada Limited) - PH100WH, PH104WH (JAMP Pharma Corporation) - 06239 (Marcan Pharmaceuticals Inc.) - 02115 (Pharmascience Inc.) - Notable Requirements: - Contracts are for off patent oncology pharmaceuticals - Awarded suppliers must comply with Canadian trade agreements (NWPTA, CFTA, TCA, CETA) - Alberta Health Services may participate depending on existing contracts - Products are intended for healthcare institutions across Canada
Description
HealthPRO Procurement Services Inc. has awarded contracts following the November 2025 market response RFP for off patent oncology pharmaceutical products primarily used by healthcare institutions. The notice details awarded contracts to multiple suppliers across Canada, including Fresenius Kabi and JAMP Pharma Corporation, with a total estimated contract value of approximately $45.6 million. The procurement supports oncology product supply for healthcare providers and is subject to trade agreements such as NWPTA, CFTA, TCA, and CETA. Alberta Health Services may participate depending on existing contracts.